Global DNA Vaccines Market Size & Trends Shows a Rapid Growth by 2027

The global DNA vaccine market is anticipated to grow at a considerable CAGR of around 7.6% during the forecast period (2021-2027). DNA vaccines are third-generation vaccines that are a quickly emerging vaccine platform for cancer, the major companies are aimed to develop DNA vaccine-based immunotherapeutic strategies for the treatment of infections, and cancer disease.

The DNA vaccines are based on decontaminated plasmid preparations containing transgenes that encode antigenic proteins which are capable of generating an immune response to a wide range of diseases. In the terms of safety, the major factors that drive the growth of the DNA vaccines are included the DNA vaccines platform provides numerous features that convene distinct benefits above other vaccine technologies such as the ease of production and constancy, DNA vaccines have released a new approach to advance multi-antigen vaccines.

Moreover, the property of specific antigen targeting developed stability, The DNA vaccines can reduce the risk of contagion as compared to conventional vaccines are projected to drive the market during the forecasted period. For Instance, In February 2019, Merck & Co., the US-based company, with d.b.a. acquired Immune Design Corporation (IDC). The company was engaged in the development of effective and safe vaccines. Through this acquisition, Merck is expected to gain access to the IDS’s various immunotherapy programs.

Global DNA Vaccine Market – Company Profiles

• Pfizer Inc.
• MERCK & CO.
• Sanofi Pasteur Inc.
• Serum Institute of India Pvt. Ltd
• INOVIO Pharmaceuticals.
• GE healthcare life sciences
• GlaxoSmithKline plc.
• Hoffmann-La Roche Ltd
• Bharat Biotech.
• GC Pharma corporate

Global DNA Vaccine Market- Segmentation

By Type

• Animal DNA Vaccine
• Human DNA Vaccine

By Application

• Oncology, Infectious Diseases
• Others

By Technology

• Plasmid DNA Vaccines Technology
• Plasmid DNA Delivery Technology

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.